Latest filing published 30 Jul 2026 for AtriCure, Inc., €438k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Sven Wehrwein, listed as board member, has filed trades across 8 companies (mainly through SEC (Form 4)), most often in SPS Commerce Inc, Uroplasty Inc and Synovis Life Technologies Inc. Between 14 March 2006 and 28 July 2026, the trades on record add up to 215 filings.
The open-market side counts 1 purchase for €3,303 alongside 88 sales for €10.8M. On balance, insiders were net sellers of €10.8M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 44 share grants and 77 option exercises. Since January 2026: no purchases and 1 sale on the market.
The newest entry dates from 30 July 2026: an option exercise of €438k, in AtriCure, Inc. The last insider purchase was made public on 27 November 2007, 6,905 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 35 declarations